BNET Industries

Restore Medical Inc.

(REST) is in the Health Care Industry

Last Fiscal Year Sales:$4.1M
  • Public
  • US
Dow Jones Description

We develop, manufacture and market our proprietary and patented Pillar ® palatal implant system (Pillar System). The Pillar System is a simple, innovative, minimally invasive, implantable medical device used to treat sleep disordered breathing, which includes mild to moderate obstructive sleep apnea, or OSA, and habitual or socially disruptive snoring. During the Pillar Procedure ® , a physician implants three small, braided, proprietary polyester inserts into the muscle of the soft palate. These Pillar inserts, together with the bodys natural fibrotic response to the implanted Pillar inserts, add structural support and stiffen the soft palate, thereby minimizing or eliminating the palatal tissue vibration that can cause snoring and the collapse that can obstruct the upper airway and cause OSA. We believe the Pillar Procedure is a safe, clinically effective, long-lasting and low-risk procedure with minimal pain or complications that offers significant benefits to both patients and physicians over other available treatment options. Our Pillar System was cleared by the United States Food and Drug Administration, or FDA, for snoring in December 2002 and for mild to moderate OSA in July 2004. Our Pillar System received CE Mark certification for both snoring and mild to moderate OSA from the European Commission in May 2003 and December 2004, respectively. ...

President, Chief Executive Officer and DirectorJ. Robert Paulson
Number of Employees 57
Contact Information

2800 Patton Rd

Saint Paul, Minnesota 55113

restoremedical....

(651) 634-3111

NAICS Code Surgical Appliance and Supplies Manufacturing: 339113

News & Analysis

Filter by

restore medical inc. - All News and Analysis

  • USA: TROOPS IN IRAQ KEEP HUMANITARIAN EFFORTS AT FOREFRONT.

    - 2009-03-18

    According to DOD: Though U.S. forces in Iraq have focused their efforts on building the nation's self-sufficiency, they have not lost sight of the need for humanitarian assistance. In recent days, U.S. forces have conducted humanitarian missions throughout Iraq to boost the quality of medical...

  • USA: U.S. TEAM EXAMINES WAYS TO BOOST CARE AT IRAQI HOSPITAL.

    - 2009-03-11

    According to DOD: Iraqi doctors from the Karama Hospital in Kut, Iraq, discussed surgery procedures, techniques and some health care challenges they face with members of the 848th Forward Surgical Team last week. The visit was part of Operation Gunner Med, a joint medical civil-military operation...

  • Grants to MDs in Hurricanes

    - 2008-10-01

    The American Medical Association Foundation's Health Care Recovery Fund will provide grants of up to $2,500 to physicians in places that have been declared disaster areas by the Federal Emergency Management Agency, and the foundation currently is accepting donations to help physicians who have been directly affected by Hurricanes Gustav...

  • Medtronic Completes Acquisition of Restore Medical

    - 2008-07-17

    MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT) today announced that it has completed its acquisition of Restore Medical, Inc. (NASDAQ: REST). Under the terms of the agreement announced on April 22, 2008, Restore shareholders will receive $1.60 per share in cash for each share of Restore common stock they own. The total...

  • Restore Medical Announces Date of Special Meeting

    - 2008-06-02

    Special Stockholders' Meeting Set for Wednesday, July 16, 2008 MINNEAPOLIS -- Restore Medical, Inc. (NASDAQ:REST) today announced that it has scheduled a special stockholders' meeting to approve its proposed merger transaction with Medtronic, Inc. (NYSE:MDT) for Wednesday, July 16, 2008, at 10:30 a.m. CDT at the offices of...

  • Restore medical improved gross profit margin in 2007

    - 2008-05-01

    Lower production costs and more efficient manufacturing operations helped Restore Medical Inc. improve its profit margin last year. Gross profit for the fourth quarter of 2007, which ended Dec. 31, was $566,000, or 72% of net sales, compared with a gross profit of $697,000, or 63% of net...

  • BellwetherReport.com Initiates Analyst Coverage on BRCM, ANAD, SIRT and REST

    - 2008-04-23

    BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have scheduled interviews with a number of...

  • Medtronic Signs Agreement to Acquire Restore Medical

    - 2008-04-22

    Medtronic Announces Acquisition of Pillar Palatal Implant System for the Treatment of Obstructive Sleep Apnea and Snoring MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT) and Restore Medical, Inc. (NASDAQ: REST) today announced that the companies have signed a definitive agreement under which Medtronic will pay $1.60 per share in...

  • OTCPicks.com Daily Market Movers Digest Midday Report for Friday, April 4th UITK, AQUI, REST, SOLM, XSNX.

    - 2008-04-04

    M2 PRESSWIRE-4 April 2008-OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, April 4th UITK, AQUI, REST, SOLM, XSNXC1994-2008 M2 COMMUNICATIONS LTD RDATE:04042008 Our Stocks to Watch today include Ultitek Ltd. (OTCBB: UITK), AQUAGOLD International Inc. (OTC: AQUI),...

  • Restore Medical Preliminary First Quarter Net Sales up 24 Percent

    - 2008-04-03

    Company to Apply to List Its Stock on Nasdaq Capital Market ST. PAUL, Minn. -- Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar([R]) Palatal Implant System, today announced preliminary net sales for the three months ended March 31, 2008. The Pillar Palatal Implant System is a proven...

Decision Makers

Name (plus bio) Position
J. Robert Paulson President, Chief Executive Officer and Director
Edward W. Numainville Vice President, Clinical & Regulatory Affairs
Mark B Knudson Founder
Anja Metzger Director, Research & Development
Philip E. Radichel Vice President, Info Sys
Stephen Kraus corporate director

Board of Directors

Name (plus bio) Position
Richard J. Nigon Chair
Ashley L. Dombkowski Board of Directors
Susan L Critzer Board of Directors

J. Robert Paulson, Jr . , age 50, was appointed President, Chief Executive Officer and a director of our company in April 2005. Prior to joining us, Mr. Paulson served as Chief Financial Officer and Vice President of Marketing for Endocardial Solutions, Inc. from August 2002 until January 2005 when it was acquired by St. Jude Medical, Inc. From 2001 to June 2002, Mr. Paulson was the Senior Vice President and General Manager of the Auditory Division of Advanced Bionics Corporation, and between 1995 and 2001, Mr. Paulson served in various capacities at Medtronic, Inc., including Vice President and General Manager of the Surgical Navigation Technologies business unit; Vice President of Corporate Strategy and Planning; and Director of Corporate Development. Mr. Paulson currently serves on the board of directors of two publicly-held medical device companies, MedicalCV Inc. and Vascular Solutions, Inc. John Schulte , age 58, has served as one of our directors since October 2001. He currently is President and Chief Executive Officer of The Spectranetics Corporation, a publicly-held manufacturer of single-use medical devices used in minimally-invasive surgical procedures within the cardiovascular system, where he has served since January 1, 2003. From October 1, 2001 to December 31, 2002, Mr. Schulte was Chief Executive Officer of Consensus Pharmaceuticals, Inc., a privately-held biotechnology company. Prior to that, Mr. Schulte served from November 1998 to October 2001 as President and Chief Executive Officer of Somnus Medical Technologies, Inc., a medical device company specializing in the design, development, manufacturing and marketing of minimally-invasive medical devices for the treatment of upper airway disorders. Mr. Schulte has served as a director of The Spectranetics Corporation since 1996.

Organization Position Status
Restore Medical, Inc. President, Chief Executive Officer and Director Current
Medicalcv, Inc. Board of Directors Current
Vascular Solutions, Inc. Board of Directors Current
The Atrilaze Board of Directors Current
Vascular Solutions, Inc. CEO Former
Endocardial Solutions, Inc. Chief Financial Officer Former
Endocardial Solutions, Inc. Vice President of Marketing Former
Medtronic, Inc. Vice President Former
Advanced Bionics Corporation General Manager Former
Medtronic, Inc. Director of Corporate Development Former
Restore Medical, Inc. Board of Directors Former
Vanderbilt University Law School Juris Doctorate Former
Vanderbilt University J.D. Former
University of St. Thomas Master of Business Administration Former
Luther College B.A. Former
Organization Position Status
Restore Medical, Inc. Vice President, Clinical & Regulatory Affairs Current
Medtronic, Inc. Former
Metropolitan State University BA in Business Former
Organization Position Status
Venturi Group, LLC Chief Executive Officer Current
EnteroMedics, Inc. President and Chief Executive Officer Current
Restore Medical, Inc. Founder Current
EnteroMedics, Inc. Chairman Current
Venturi Group, LLC Chairman Current
Allegro Biodiesel Corporation Board of Directors Current
American Heart Association, Inc. Fellow Current
Restore Medical, Inc. President Former
University of Washington School of Medicine Board of Directors Former
Incontrol Board of Directors Former
Integ Board of Directors Former
Washington State University Ph.D. In Cardiovascular Physiology Former
Washington State University Bachelor of Science Degree Former
University of Washington School of Medicine Member Former
Organization Position Status
Restore Medical, Inc. Director, Research & Development Current
Organization Position Status
Restore Medical, Inc. Vice President, Info Sys Current
Restore Medical, Inc. Director, Sys Former
Integ Systems Manager Former
University of Minnesota BSEE Former
Organization Position Status
Restore Medical, Inc. corporate director Current
Transave, Inc. Current
Ironwood Capital Director Current
Acelero Learning Board of Directors Current
Restore Medical, Inc. Board of Directors Current
Yale University B.A. Former
Organization Position Status
Restore Medical, Inc. Chair Current
Vascular Solutions, Inc. Chairman Current
Physicians Onsite Director Current
Incisive Surgical, Inc. Board of Directors Current
Vascular Solutions, Inc. Board of Directors Current
Virtual Radiologic Corporation Board of Directors Current
Danti's Chief Financial Officer Former
Danti's Executive Vice President Former
Danti's Senior Vice President Former
Stifel Financial Corp. Managing Director of Private Placements Former
Restore Medical, Inc. Board of Directors Current
Organization Position Status
MPM Capital Limited Partnership General Partner Current
Restore Medical, Inc. Board of Directors Current
Sonic Innovations, Inc. Former
Rigel Corporation Board Member Former
NeoRx Corporation Board Member Former
Portola Pharmaceuticals, Inc. Board Member Former
EnteroMedics, Inc. Board Member Former
Tercica, Inc. Board Member Former
Peptimmune, Inc. Board Member Former
Rice University Ph.D. in Mathematics Former
Wellesley College B.A. Former
Organization Position Status
University of St. Thomas Adjunct Professor Current
Venturi Group, LLC Current
Medicalcv, Inc. Chairperson of the Board Current
The Atrilaze Chairperson of the Board Current
Restore Medical, Inc. Board of Directors Current
Restore Medical, Inc. Chief Executive Officer Former
Integ Chief Executive Officer Former
Integ President Former
Restore Medical, Inc. President Former
Integ Acting Chief Financial Officer Former
Restore Medical, Inc. Chief Financial Officer Former
Integ Vice President, Operations Former
American Cyanamid Company Former
University of Michigan MBA Former
Kettering University BSME Former

Executive News

  • Nicholas Teti to Consult as Special Advisor to the Chief Executive Officer, Commercialization...

    Forbes.com - 6/02/09 - View Story

  • Nicholas Teti to Consult as Special Advisor to the Chief Executive Officer, Commercialization and Business Development

    Business Wire - 6/02/09 - View Story